Granted Patent
B2
US 9,828,349 · App. 14/954,263 · Granted Nov 28, 2017
1-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl amines and related compounds having analgesic and/or immuno stimulant activity
Inventors:
Bertrand Leblond (Paris, FR); Eric Beusoleil (Paris, FR); Thierry Taverne (St. Martin Boulogne sur Mer, FR); John E. Donello (Dana Point, CA)
C07D265/30A61K31/40A61K31/4025A61K31/4409A61K31/4439A61K31/4545A61K31/4709A61K31/496A61K31/5375A61K31/5377A61K31/541C07D207/09C07D213/64C07D295/12C07D295/13C07D295/15C07D319/18C07D405/06
View Patent ↗
Loading inventors, assignments & file history…
Abstract
Compounds of the formula where the variables have the meaning defined in the specification have analgesic and/or immunostimulant effect in mammals.
Claims (5)
1. A compound, wherein the compound is:
or a pharmaceutically acceptable salt thereof.
2. A method of treating pain in a mammal, the method comprising the step of administering to said mammal in need of such treatment a compound in accordance with claim 1 or a pharmaceutically acceptable salt thereof.
3. The method of claim 2 , wherein said pain is chronic pain.
4. A pharmaceutical composition comprising a compound in accordance with claim 1 , or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable excipient.
Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Oct 18, 2016
From: BEAUSOLEIL, ERIC; LEBLOND, BERTRAND; TAVERNE, THIERRY; DONELLO, JOHN E.
To: ALLERGAN, INC.
Reel/Frame 040045/0575 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Oct 18, 2016
From: ALLERGAN, INC.
To: EXONHIT THERAPEUTICS SA
Reel/Frame 040045/0764 →
Continuity (5)
Continuation
11814601
Provisional Application
60647271
· Jan 26, 2005